El fenómeno de Raynaud

作者: Carles Tolosa Vilella , Carmen Pilar Simeón Aznar , Lourdes Gabarró Julià

DOI: 10.1016/J.MEDCLI.2008.11.017

关键词:

摘要: Raynaud's phenomenon is a frequent reason for seeking of medical attention, since it affects 3-5% the population. It characterized by sudden, transient and recurrent episodes pallor and/or digital cyanosis, after exposure to cold or stressful situations. No known underlying illness identified in over 80% cases consequently these are classified as primary phenomenon. Connective tissue diseases, particularly systemic sclerosis, main causes Once complete clinical physical evaluation rule out other causes, nailfold capillaroscopy antinuclear antibodies determination most useful adjunctive tests. Mild can be managed almost exclusively with conservative non-pharmacological lifestyle modifications. However, if patient develops severe vascular condition suitable vasodilator treatment needed. When critical ischemia develops, intravenous prostaglandin analogues surgery may useful.

参考文章(52)
Black Cm, Stratton Rj, Howell K, Denton Cp, Long-term low molecular weight heparin therapy for severe Raynaud's phenomenon: a pilot study. Clinical and Experimental Rheumatology. ,vol. 18, pp. 499- 502 ,(2000)
Francesco Boin, Fredrick M Wigley, Understanding, assessing and treating Raynaud's phenomenon. Current Opinion in Rheumatology. ,vol. 17, pp. 752- 760 ,(2006) , 10.1097/01.BOR.0000179944.35400.6E
LeRoy Ec, Medsger Ta, Raynaud's phenomenon: a proposal for classification. Clinical and Experimental Rheumatology. ,vol. 10, pp. 485- 488 ,(1992)
G. Riera, B. Bermejo, J. Vaque, V. Fonollosa, M. Vilardell, Prevalence of Raynaud's phenomenon in a healthy spanish population The Journal of Rheumatology. ,vol. 20, pp. 66- 69 ,(1993)
Manuel Ramos-Casals, Gloria de la Red, Josep Font, Ricard Cervera, Miguel Ingelmo, Susana Lasterra, José Rosas, Antoni Sisó, Mario García-Carrasco, Victor Gil, Raynaud's phenomenon in primary Sjögren's syndrome. Prevalence and clinical characteristics in a series of 320 patients. The Journal of Rheumatology. ,vol. 29, pp. 726- 730 ,(2002)
Elizabeth Benito-Garcia, Peter H. Schur, Robert Lahita, , Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-Sm and anti-RNP antibody tests. Arthritis Care and Research. ,vol. 51, pp. 1030- 1044 ,(2004) , 10.1002/ART.20836
Arthur F. Kavanaugh, Daniel H. Solomon, , Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests Arthritis & Rheumatism. ,vol. 47, pp. 546- 555 ,(2002) , 10.1002/ART.10558
Liana Fraenkel, Yuqing Zhang, Christine E Chaisson, Stephen R Evans, Peter WF Wilson, David T Felson, The Association of Estrogen Replacement Therapy and the Raynaud Phenomenon in Postmenopausal Women Annals of Internal Medicine. ,vol. 129, pp. 208- 211 ,(1998) , 10.7326/0003-4819-129-3-199808010-00009
Ariane Herrick, Diagnosis and management of scleroderma peripheral vascular disease. Rheumatic Diseases Clinics of North America. ,vol. 34, pp. 89- 114 ,(2008) , 10.1016/J.RDC.2007.11.006
Niels Olsen, Steen Levin Nielsen, Prevalence of primary Raynaud phenomena in young females Scandinavian Journal of Clinical & Laboratory Investigation. ,vol. 38, pp. 761- 764 ,(1978) , 10.1080/00365517809104884